SCHEMBL2470101

SCHEMBL2470101

S=C(Oc1ccccc1)Oc1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 2/20 0.45
TSHR P16473 1/20 0.45
TDP1 Q9NUW8 2/20 0.43
ATM Q13315 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
CA5A P35218 1/20 0.42
CA5B Q9Y2D0 1/20 0.42
ALOX15 P16050 2/20 0.41
HPGD P15428 1/20 0.41
HSD17B10 Q99714 1/20 0.41
CA4 P22748 1/20 0.41
NR1H2 P55055 1/20 0.40
BAX Q07812 1/20 0.40
KDM4E B2RXH2 1/20 0.39
MAPT P10636 1/20 0.39
NSD2 O96028 1/20 0.39
ALDH1A1 P00352 1/20 0.39
RECQL P46063 1/20 0.39
SRC P12931 1/20 0.39
KCNA3 P22001 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5515233 0.89 LTA4H (0.41) LTA4HTSHRTDP1ATML3MBTL1
SCHEMBL14823291 0.86 LMNA (0.48) TSHRHPGDKDM4EMAPTALDH1A1
SCHEMBL2469364 0.86 CA4 (0.61) LTA4HTDP1CA4MAPTALDH1A1
SCHEMBL2465447 0.86 ALDH1A1 (0.42) LTA4HATML3MBTL1ALOX15HPGD
SCHEMBL2461968 0.86 ALDH1A1 (0.44) LTA4HTDP1L3MBTL1CA5ACA5B
SCHEMBL8238327 0.85 CA4 (0.46) LTA4HTSHRTDP1ATML3MBTL1
SCHEMBL3076764 0.85 LTA4H (0.38) LTA4HTSHRTDP1ATML3MBTL1
SCHEMBL192581 0.85 LTA4H (0.38) LTA4HTSHRTDP1ATML3MBTL1
SCHEMBL3085032 0.83 TDP1 (0.36) LTA4HTSHRTDP1ATML3MBTL1
SCHEMBL2463525 0.82 TDP1 (0.55) TDP1L3MBTL1HSD17B10KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119736658-A Multi-carbon-layer metal atom-loaded material and preparation method thereof 中国科学院城市环境研究所 2025-04-01 CN claimed
CN-122055400-A Composition, prepreg and metal-clad laminate AGC株式会社 2026-05-15 CN disclosed
CN-122029231-A Resin composition, prepreg, metal-clad laminate, and method for producing same AGC株式会社 2026-05-12 CN disclosed
US-20260085154-A1 POLYMER, COMPOSITION, CURED PRODUCT, LAMINATED BODY, AND ELECTRONIC COMPONENT JSR CORPORATION (JP) 2026-03-26 US disclosed
WO-2025084303-A1 RESIN COMPOSITION, PREPREG, METAL-CLAD LAMINATE, AND METHOD FOR PRODUCING SAME AGC株式会社 2025-04-24 WO disclosed
WO-2025084304-A1 COMPOSITION, PREPREG, AND METAL-CLAD LAMINATED BOARD AGC株式会社 2025-04-24 WO disclosed
CN-119736658-A Multi-carbon-layer metal atom-loaded material and preparation method thereof 中国科学院城市环境研究所 2025-04-01 CN disclosed
CN-119317656-A Polymer, composition, cured product, laminate, and electronic component JSR株式会社 2025-01-14 CN disclosed
WO-2024257781-A1 THERMOSETTING RESIN COMPOSITION FOR FORMING WIRING BOARD, CURED PRODUCT, PREPREG, AND INTERLAYER INSULATING FILM JSR株式会社 2024-12-19 WO disclosed
WO-2024053282-A1 POLYMER, COMPOSITION, CURED PRODUCT, LAMINATE, AND ELECTRONIC COMPONENT JSR株式会社 2024-03-14 WO disclosed
WO-1994019329-A1 SUBSTITUTED CYCLIC CARBONYLS AND DERIVATIVES THEREOF USEFUL AS RETROVIRAL PROTEASE INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1994-09-01 WO disclosed
EP-0607334-A1 CYCLIC UREAS AND ANALOGUES USEFUL AS RETROVIRAL PROTEASE INHIBITIORS. DU PONT MERCK PHARMA (US) 1994-07-27 EP disclosed
US-5246927-A Nematocides and anthelmintics CIBA-GEIGY CORPORATION (US) 1993-09-21 US disclosed
WO-1993007128-A1 CYCLIC UREAS AND ANALOGUES USEFUL AS RETROVIRAL PROTEASE INHIBITIORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1993-04-15 WO disclosed
EP-0356385-A2 New benzazole derivatives, processes for their preparation and pharmaceutical preparations containing such compounds and the use thereof CIBA-GEIGY AG (CH) 1990-02-28 EP disclosed
US-4876266-A DOPAMINE-B-HYDROXYLASE INHIBITORS SMITHKLINE BECKMAN CORPORATION (US) 1989-10-24 US disclosed
EP-0329900-A1 Substituted 1-aralkyl imidazoline-2-thiols SMITHKLINE BEECHAM CORPORATION (US) 1989-08-30 EP disclosed
WO-1989006126-A1 1-ARALKYL-2-MERCAPTOIMIDAZOLINES AS DOPAMINE-beta-HYDROXYLASE INHIBITORS SMITHKLINE BECKMAN CORPORATION (US) 1989-07-13 WO disclosed
US-4695644-A Process for producing phenyl chlorothioformates TOYO SODA MANUFACTURING CO., LTD. (JP) 1987-09-22 US disclosed
US-4399075-A Process for producing chlorinated phenoxytoluene derivatives ASAHI CHEMICAL COMPANY, LIMITED (JP) 1983-08-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260085154-A1 POLYMER, COMPOSITION, CURED PRODUCT, LAMINATED BODY, AND ELECTRONIC COMPONENT RER1, COL1A1, SMC1A LTA4H 980/4885TSHR 2773/4885TDP1 2901/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.